Summary by Moomoo AI
Eli Lilly and Co announced the issuance of $6.5 billion in new notes, divided into five tranches with varying interest rates and maturity dates. The tranches include $1 billion of 4.500% notes due 2027, $1 billion of 4.500% notes due 2029, $1.5 billion of 4.700% notes due 2034, $1.5 billion of 5.000% notes due 2054, and $1.5 billion of 5.100% notes due 2064. Interest on these notes is payable semi-annually on February 9 and August 9. The notes are unsecured and rank equally with Eli Lilly's other unsecured and unsubordinated debt. The offering involves joint book-running managers Barclays, BofA Securities, Citigroup, Deutsche Bank Securities, and Mizuho, along with co-managers including Academy Securities, CastleOak Securities, L.P., R. Seelaus & Co., LLC, Ramirez & Co., Inc., Cabrera Capital Markets LLC, Independence Point Securities, Loop Capital Markets, Penserra...Show More